Atlas Trials

A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma

Clinical trial NCT03008408 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03008408
Sponsor
M.D. Anderson Cancer Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Endometrial CarcinomaRecurrent Endometrial Endometrioid AdenocarcinomaRefractory Endometrial CarcinomaRefractory Endometrial Endometrioid AdenocarcinomaStage III Uterine Corpus Cancer AJCC v8Stage IIIA Uterine Corpus Cancer AJCC v8Stage IIIB Uterine Corpus Cancer AJCC v8Stage IIIC Uterine Corpus Cancer AJCC v8Stage IIIC1 Uterine Corpus Cancer AJCC v8Stage IIIC2 Uterine Corpus Cancer AJCC v8Stage IV Uterine Corpus Cancer AJCC v8Stage IVA Uterine Corpus Cancer AJCC v8
Start date
2017-08-18
Primary completion
2028-08-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.